§ Funding Round
Series A funding round for Enliven Therapeutics raising $55M in December 2020
Series A funding round for Enliven Therapeutics raising $55M in December 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
Westlake Village BioPartners | — | — |
| Angel | mira chaurushiya | |
Roche | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$220M
Top Valuation
-
Enliven Therapeutics raised $55M in a Series A round.
The round was announced on 12/01/20.
